Latest news with #Starvision
Observer
15-06-2025
- Business
- Observer
Oman Lens partners with Bahrain Space Agency
MUSCAT, JUNE 15 Omani space start-up Oman Lens has partnered with Bahrain's Space Agency and China based Starvision to launch an AI-powered payload on board its satellite OL-1, marking the first Omani-Bahraini collaboration in the space sector. The collaboration enabled the launch of the first specialised payload for detecting and identifying clouds in satellite images using advanced artificial intelligence (AI) technologies, according to SpaceTech Gulf, a leading analytics and space market intelligence company in the Gulf and MENA regions. In a statement, Oman Lens shared the following, 'Oman Lens expresses its pride and delight in the fruitful collaboration with the Bahrain Space Agency and China's Starvision in the implementation of a pioneering project that marks a significant step forward in the use of artificial intelligence for satellite image analysis to detect and identify clouds.' The Omani start-up further added: 'This project represents a key milestone in our journey to enhance the use of advanced technologies in the space sector and reflects our commitment to building strategic partnerships that support knowledge localisation and foster innovation across the Arab world.' Speaking to the media, Dr Mohammed Ibrahim al Aseeri, Chief Executive Officer of the Bahrain Space Agency, highlighted the significance of the project, 'This project marks another milestone in the accomplishments of the Bahrain Space Agency and contributes to strengthening Bahrain's position among leading nations in the space sector. It is also a clear testament to the agency's wide-ranging international partnerships, the technical progress made by its members, and the scientific and practical competencies that paved the way for this exceptional and high-value collaboration.' Space engineer Yaqoub al Qassab at the agency added that the project is part of a set of initiatives aimed at strengthening local space capacities. 'This project is part of a series of initiatives aimed at building national capacity in the development and integration of AI algorithms with satellite components. The technical team behind the project forms the nucleus of a specialised Bahraini team focused on applying AI technologies in space, serving sustainable development goals,' he said. According to Al Qassab, the agency is currently in the process of creating new algorithms for the detection of marine vessels. Satellite OL-1 successfully launched last November 2024, on board Chinese commercial carrier rocket Lijian-1 Y5 from the Dongfeng Commercial Aerospace Innovation Test Zone. It recently marked 5,000 hours of continuous orbital operations. Oman Lens shared that data from the satellite will be used to monitor the country's landscapes, infrastructure and natural resources. It is also the first of a planned constellation of 20 satellites.
Korea Herald
07-05-2025
- Business
- Korea Herald
Lunit to Power Germany's Largest Private Radiology Network with AI Imaging
The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Lunit (KRX: a leading provider of AI for cancer diagnostics and therapeutics, today announced a strategic partnership with Starvision Service GmbH, Germany's largest private radiology network. Through a newly signed framework agreement, Lunit's AI imaging solutions will be deployed across Starvision's expansive network of radiological practices. Starvision operates 79 locations across seven German federal states, delivering services in radiology, nuclear medicine, and radiation therapy. As a recognized leader in the DACH healthcare market, Starvision is known for its commitment to digital transformation, operational excellence, and high-quality patient care. Under the agreement, Starvision will adopt several of Lunit's AI solutions, including: The first commercial deployments are already underway—including use of Lunit INSIGHT MMG at Radiologische Allianz in Hamburg, supporting the Hamburg breast cancer screening program under the Starvision network. Together with deployments at Die Radiologie, a major regional hospital group operating over 20 medical sites across Bavaria, Lunit's solutions are now supporting approximately 120,000 breast cancer screenings and diagnoses annually across the two institutions. The five-year framework agreement allows additional Starvision locations—and newly affiliated practices—to join at any time, enabling broad scalability across the network. New deployments and clinical trials are already in progress, with individual agreements being signed across Starvision's entities as part of a phased implementation plan. Beyond Starvision, several other healthcare providers across Germany have also expressed interest, reflecting the expanding demand for AI-driven imaging solutions. "Lunit's AI solutions support our radiologists in delivering fast and accurate diagnoses. This strengthens diagnostic confidence and gives us more time to focus on what truly matters: the individual care of our patients," said Uwe Pfeifer, CEO of Starvision Service GmbH. "Partnering with Starvision accelerates our vision of bringing AI-powered precision diagnostics into everyday clinical practice," said Brandon Suh, CEO of Lunit. "Together, we are advancing a new era of radiology where technology enhances the expertise of physicians, delivering better outcomes for millions of patients in Germany and beyond." The partnership supports both companies' vision of transforming healthcare through intelligent technology and setting new standards in radiology. About Lunit Founded in 2013, Lunit (KRX: is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit's FDA-cleared Lunit INSIGHT suite supports cancer screening at over 4,800 medical institutions in more than 55 countries. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology —and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at
